Get a jump start on the US trading day with Matt Miller and Katie Greifeld on "Bloomberg Open Interest." Ukrainian President Volodymyr Zelenskiy and his European allies meet President Trump in Washington today. Retail earnings this week will shed light on the health of US consumers. Novo Nordisk is slashing the cost of Ozempic for cash-paying patients to $499 a month and partnering with GoodRx to offer it at the same price at US pharmacies. GoodRx CEO talks to Open Interest about offering the best prices on drugs to consumers.

See Full Page